These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28351466)

  • 1. ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.
    Bachmann CJ; Philipsen A; Hoffmann F
    Dtsch Arztebl Int; 2017 Mar; 114(9):141-148. PubMed ID: 28351466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Age- and Gender-specific Costs as Well as Drug Therapies of ADHD Patients].
    Klora M; Zeidler J; Lublow D; Linder R; Verheyen F; von der Schulenburg JM
    Gesundheitswesen; 2016 Jul; 78(7):e23-9. PubMed ID: 26695543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
    Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
    McCarthy S; Wilton L; Murray ML; Hodgkins P; Asherson P; Wong IC
    BMC Pediatr; 2012 Jun; 12():78. PubMed ID: 22712630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
    Brault MC; Lacourse É
    Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
    Schubert I; Köster I; Lehmkuhl G
    Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015.
    Mac Avin M; Teeling M; Bennett KE
    BMJ Open; 2020 Apr; 10(4):e035716. PubMed ID: 32327478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.
    Song I; Shin JY
    Epidemiol Health; 2016; 38():e2016045. PubMed ID: 27866408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.
    Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Huang TS; Chou WJ; Chou MC; Lee MJ; Lee TL; Shyu YC
    Epidemiol Psychiatr Sci; 2017 Dec; 26(6):624-634. PubMed ID: 27435692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany.
    Akmatov MK; Holstiege J; Bätzing J
    BMC Psychiatry; 2021 Aug; 21(1):405. PubMed ID: 34391396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.
    Bachmann CJ; Wijlaars LP; Kalverdijk LJ; Burcu M; Glaeske G; Schuiling-Veninga CCM; Hoffmann F; Aagaard L; Zito JM
    Eur Neuropsychopharmacol; 2017 May; 27(5):484-493. PubMed ID: 28336088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Explanations for Increasing Methylphenidate Use in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany From 2004 to 2013.
    Langner I; Haug U; Scholle O; Lindemann C; Schröder C; Riedel O
    J Clin Psychopharmacol; 2019; 39(1):39-45. PubMed ID: 30489381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.
    Robison LM; Skaer TL; Sclar DA; Galin RS
    CNS Drugs; 2002; 16(2):129-37. PubMed ID: 11825103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011.
    Hong M; Kwack YS; Joung YS; Lee SI; Kim B; Sohn SH; Chung US; Yang J; Bhang SY; Hwang JW; Choi HY; Oh IH; Lee YJ; Bahn GH
    Asia Pac Psychiatry; 2014 Dec; 6(4):379-85. PubMed ID: 25277653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.